Every Form 4 that SRX GLOBAL INC (SRXH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SRXH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SRXH filings page.
SRx Health Solutions, Inc. Chief Executive Officer Kent Douglas Cunningham reported multiple equity awards that increase his ownership exposure, with no sales disclosed. On March 16, 2026, he received 247,522 Series B Warrants with an exercise price of $0.3182 per share, exercisable into the same number of common shares and expiring on March 16, 2029. On the same date he was also granted 63 shares of Series B Preferred Stock at $800 per share. Earlier awards include common stock grants of 231,193 shares on August 25, 2025 and 200,000 shares on December 3, 2025, both recorded as grants/awards rather than open-market purchases. One 44,464-share common stock position is held indirectly through Halo Spin-Out SPV Inc. The filing also reports a prior grant of 8,000 stock options with a $5.00 exercise price and 8,000 underlying common shares, along with several smaller common stock awards, all categorized as compensation-related acquisitions.
Conway Simon Alexander Malcolm reported acquisition or exercise transactions in this Form 4 filing.
SRx Health Solutions, Inc. director Conway Simon Alexander Malcolm reported two compensation-related stock awards of common shares. On August 25, 2025, he received 154,128 shares at a stated value of $0.40 per share, and on December 3, 2025, he received 630,000 shares at $0.39 per share. These are classified as grants or awards, not open‑market purchases. Following the most recent award, he directly holds 834,792 common shares.
David Allan White, a newly appointed director of SRx Health Solutions, Inc. (SRXH), reported multiple stock acquisitions tied to his appointment. The Form 4 shows acquisitions on 04/24/2025, 05/01/2025, and 08/25/2025 totaling 344,975 shares held after the latest transaction and a separate block of 6,200 shares held directly. Prices per share for the reported purchases were $2.09, $1.23, and $0.40 respectively. The filing also reports 69,732 common stock purchase warrants exercisable on 07/07/2025 with a $0.62 exercise price expiring on 07/07/2028. The filer notes the reported shares reflect holdings as of his appointment as director on 04/24/2025.